Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 5c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.98), $0.05 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $119 million versus the consensus estimate of $132.7 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
• AIRO Group Holdings, Inc. (AIRO) Reports Q2 Loss of $0.06
• SBC Medical Group Holdings Incorporated (SBC) Misses Q2 EPS by 2c